Biography

Andrew studied for his B.Sc.(Adv.) at the Australian National University and received a First Class Honours degree in 2009. He began his Ph.D. in 2010 with Assoc. Prof. Russell Barrow at the Research School of Chemistry as an Alan Sargeson Scholar, focusing on the synthesis of biologically active natural products from fungi used by tribes from Papua New Guinea. In 2014, he won an Endeavour Research Fellowship to train with Assoc. Prof. Gregory Dake at the University of British Columbia, Department of Chemistry, Vancouver, Canada. Whilst at UBC Andrew designed new organometallic controlled reactions to prepare natural products.

In 2015, Andrew moved to the University of East Anglia, School of Pharmacy to work with Dr Lesley Howell, examining the protein-protein interaction of Mcl-1 and NOXA, proteins which regulate apoptosis and are commonly exploited by cancers. In 2016, Andrew began working with Prof. Mark Searcey, on the common fruit metabolites as anti-inflammatory agents, and the targeting of small mlecules to DNA trinucleotide repeat disorders.

Andrew took up a position as an Independent Research Fellow in the School of Pharmacy in February 2017, and as a Lecturer in Medicinal Chemistry in April 2019. His research interests include developing new methods to target protein-protein interactions, finding new pharmaceutical leads and chemical probes for protein-protein interactions, and new molecular recogntion strutures for delivery warhead compounds.

View graph of relations

ID: 54953119